Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
05/07/2003 | EP0836648B1 Recombinant mva virus, and the use thereof |
05/07/2003 | EP0814822B1 Use of lactobacillus reuteri to inhibit cryptosporidiosis in mammals |
05/07/2003 | CN1416471A Recombinant rhabdoviruses as Live-Viral vaccines for immunodoeficiency viruses |
05/07/2003 | CN1416462A Techniques for growth and differentiatition of human pluripotent stem cells |
05/07/2003 | CN1416354A Vascular endothelial growth factor 2 |
05/07/2003 | CN1416350A Novel method for down-regulation of amyloid |
05/07/2003 | CN1415372A Medicament compsn. for curing acute pharyngitis and its preparation method |
05/07/2003 | CN1415371A Medicament for curing colpitis mycotica and trichomonal vaginitis and its preparation method |
05/07/2003 | CN1415356A Medicament containing snail powder |
05/07/2003 | CN1415355A Method for preparing capsule of snail powder |
05/07/2003 | CN1415349A Scorpion medicament for curing psoriasis and its producing method |
05/07/2003 | CN1415346A Oral liquid for nephrosis |
05/07/2003 | CN1415340A Patent Chinese medicine for curing vascular headache |
05/07/2003 | CN1415333A Tablet for curing prostatitis |
05/07/2003 | CN1415332A Capsule for curing diabetes and its preparation method |
05/07/2003 | CN1415329A Compund paste of donkey-skin gelatin for enriching the blood |
05/07/2003 | CN1415328A Stilbene paste capsule of rising white blood cell for curing disease of leucopenia |
05/07/2003 | CN1415314A Health protection tea for reducing blood fat |
05/07/2003 | CN1415313A Oral dosing calcium tablet produced from shark |
05/07/2003 | CN1415312A Application of preparing health products of anti-anoxia made from concentrated powder of non-denatured lactalbumin |
05/07/2003 | CN1415286A Antibiotic antiinflammation preparation made from extract product of Yunnan loquat as essential component |
05/07/2003 | CN1107520C Oral liquid of gingko |
05/07/2003 | CN1107516C Antiabortifacient for treating male endocrine Sterility and its preparing process |
05/07/2003 | CN1107515C Prepn. of external-applied medicine for mastoproliferation |
05/07/2003 | CN1107514C Laxative and its prepn. process |
05/07/2003 | CN1107513C Acupoint plaster agent for treating cough, asthma and diarrhea |
05/07/2003 | CN1107512C External-applied Chinese-medicinal liniment for treating alopecia areata, seborrheic alopecia and bald |
05/07/2003 | CN1107510C Burn and scald treating medicine and its prepn. |
05/06/2003 | US6559130 Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer |
05/06/2003 | US6558951 Induction of maturation of dendritic cells; obtain immature dendritic cells, incubate with modulator, monitor development and recover dendritic cells |
05/06/2003 | US6558932 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
05/06/2003 | US6558665 Selective withdrawal system in which spout formed by removal of entrained fluid remains stationary |
05/06/2003 | US6558664 Chondrocyte cell-lines |
05/06/2003 | US6558662 Treatment of hematologic disorders |
05/06/2003 | US6558656 Oral and topical compositions and methods related thereto in the treatment of acne |
05/06/2003 | US6557487 Method and device for rearing insects, especially for obtaining a secretion from fly larvae for therapeutic application |
05/06/2003 | CA2106955C Product and method for improving keratinocyte adhesion to the dermis |
05/02/2003 | EP1306427A1 Method of proliferating natural killer cells |
05/02/2003 | EP1306426A1 In vitro micro-organs, and uses related thereto |
05/02/2003 | EP1305435A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
05/02/2003 | EP1305414A2 Modified cea and uses thereof |
05/02/2003 | EP1305410A2 Insulin producing cell-line obtained by electrofusion |
05/02/2003 | EP1305409A2 Renal regulatory elements and methods of use thereof |
05/02/2003 | EP1305400A2 Adult human dental pulp stem cells in vitro and in vivo |
05/02/2003 | EP1305382A1 Purifying crude pufa oils |
05/02/2003 | EP1305038A2 Bacteriophage having multiple host range |
05/02/2003 | EP1223966B1 Use of gdnf for treating corneal defects |
05/02/2003 | EP1109564A4 Method for removal of hiv and other viruses from blood |
05/02/2003 | EP0948266B1 Ubiquinone-containing, non-alcoholic beverage |
05/02/2003 | EP0879294B1 Transduced human hematopoietic stem cells |
05/02/2003 | EP0876397B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
05/02/2003 | EP0854874B1 Macrocyclic lactone compounds and their production process |
05/02/2003 | EP0653062B1 Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations |
05/02/2003 | EP0592521B1 Marrow-derived human mesenchymal stem cells and monoclonal antibodies specific for said cells |
05/01/2003 | WO2003035884A2 Transient immortalization |
05/01/2003 | WO2003035883A2 Methods and compositions for inducing tumor-specific cytotoxicity |
05/01/2003 | WO2003035879A2 Promoters to control cell differentiation |
05/01/2003 | WO2003035855A1 Differentiation of whole bone marrow |
05/01/2003 | WO2003035851A1 In vitro micro-organs, and uses related thereto |
05/01/2003 | WO2003035838A2 Stem cells that transform to beating cardiomyocytes |
05/01/2003 | WO2003035685A1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy |
05/01/2003 | WO2003035679A2 Molecules |
05/01/2003 | WO2003035110A1 Treating vascular disease by inhibiting toll-like receptor-4 |
05/01/2003 | WO2003035101A1 A method of treatment and agents useful for same |
05/01/2003 | WO2003035012A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
05/01/2003 | WO2003034981A2 Prevention of recurrent viral disease |
05/01/2003 | WO2003034820A1 Th1 CELL ADOPTIVE IMMUNOTHERAPY |
05/01/2003 | WO2003020955A3 Use of recipient endothelial cells for enhanced vascularization of tissue and tissue-engineered construct transplants |
05/01/2003 | WO2003008558A3 Cd4+cd25+ inhibitory hybridoma clones |
05/01/2003 | WO2002100335A3 Methods for improving cell line activity in immunoisolation devices |
05/01/2003 | WO2002081513A3 Disease-associated protein |
05/01/2003 | WO2002078741A3 Methods and compositions for modulating the immune system of animals |
05/01/2003 | WO2002076391A3 Microbial feeds for aquaculture and agriculture |
05/01/2003 | WO2002053017A3 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
05/01/2003 | WO2001066572A3 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
05/01/2003 | WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
05/01/2003 | US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
05/01/2003 | US20030083233 Aqueous mixtures of oxygen-carrying and non-oxygen carrying plasma expanders; oxygen-carrying component consists of hemoglobin-based oxygen carrier, non-oxygen carrying plasma expander consists of diluent; blood substitutes |
05/01/2003 | US20030083229 Isolating T cells from mammal, incubating cells with protein expression product of activated oncogene or cancer-related gene associated with malignancy, detecting presence or absence of proliferation of T cells, determining malignancy |
05/01/2003 | US20030083226 Composition having reverse transcriptase inhibitor activity |
05/01/2003 | US20030082810 Methods for generating insulin-secreting cells suitable for transplantation |
05/01/2003 | US20030082805 Methods for use of mpl ligands with primitive human stem cells |
05/01/2003 | US20030082803 Classification of pluripotent cells in mixed cell pool; prepare nutrient broth containing enzyme inhibitor, inoculate broth, monitor broth for cells with reduced kinase expression, determine and recover pluripotent cells |
05/01/2003 | US20030082802 Preparing culture of nervous system tissues; prepare nutrient broth containing agonist, inoculate with nervous system stem cells, propagate and recover cells |
05/01/2003 | US20030082800 Expression vector for use in the generation of single stranded nucleotide sequences |
05/01/2003 | US20030082792 Biocontrol for plants with bacillus subtilis, pseudomonas putida, and sporobolomyces roseus |
05/01/2003 | US20030082791 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids |
05/01/2003 | US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein |
05/01/2003 | US20030082722 Method for amplifying expression from a cell specific promoter |
05/01/2003 | US20030082515 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator |
05/01/2003 | US20030082510 Treatment for viral or bacterial infections of blood; obtain blood sample, incubate with test compound, expose to light, evaluate sample for presence active pathogen |
05/01/2003 | US20030082223 Mixture contains flow control agent and thickener |
05/01/2003 | US20030082206 Method of preserving infectious recombinant viruses, aqueous viral suspension, and use as medicament |
05/01/2003 | US20030082195 Method of enhancing an immune response |
05/01/2003 | US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases |
05/01/2003 | US20030082160 Differentiation of whole bone marrow |
05/01/2003 | US20030082159 Lentiviral vector-mediated gene transfer and uses thereof |
05/01/2003 | US20030082158 Production of transduced hematopoietic progenitor cells |
05/01/2003 | US20030082156 Detecting disease antigen; anticancer agents |
05/01/2003 | US20030082155 Antidiabetic agents; cell differentiation of stem cells |